Purpose: The aim of this study was to determine whether long-term wear of a fluid-filled scleral lens alters basal tear production, corneal sensation, corneal nerve density, and corneal nerve morphology in 2 disease categories.
T he prosthetic device used in the Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) treatment program (BostonSight, Boston, MA) is a custom-designed scleral lens, which provides a fluid-filled reservoir that protects the corneal surface from lid-or lash-related microtrauma, prevents corneal desiccation, and neutralizes corneal irregularities. Each prosthetic device is custom fit for each patient's eye. The device is generally worn during waking hours and removed during sleep, with fresh saline placed in the reservoir every morning. The current literature supports the use of PROSE to treat a wide variety of ocular diseases with the majority of indications falling into 2 broad categories: distorted corneas (DC) such as keratoconus, pellucid marginal degeneration, irregular astigmatism, or postlaser vision correction ectasia; and ocular surface disease (OSD) such as severe dry eye syndrome (DES), ocular graft-versus-host disease, or Stevens-Johnson syndrome. [1] [2] [3] [4] [5] Despite the widespread use and extensive clinical indications for PROSE treatment, there have been few studies on the effects of long-term scleral lens wear on corneal physiology, and in particular, the effects on the lacrimal functional unit (LFU). The LFU is a conceptualized integrated unit comprised of the physical surface of the eye, tearsecreting glands, corneal nerves, and neuroendocrine factors. It regulates the tear film in response to both exogenous environmental influences and to endogenous endocrine influences. Damage to any component of the LFU alters the tear film, leading to eye desiccation. [6] [7] [8] Traditional contact lens wear has numerous effects on the LFU, such as mechanically disrupting the tear film structure and decreasing tear evaporation rate. 6, 9, 10 Contact lens wear has also been shown to decrease corneal sensation. 11, 12 The mechanism is unknown, but may be due to neural adaptation to the continuous presence of a contact lens, 11 or due to changes in the corneal subbasal nerve density. [13] [14] [15] This change in the functional and/or anatomic status of the corneal nerves in turn affects the afferent limb of the lacrimation (tearing) reflex, serving to decrease tear secretion.
We hypothesize that a PROSE prosthetic device, which maintains a fluid layer over the cornea, may also affect the LFU through changes in corneal innervation and alteration of lacrimation. We further hypothesize that wearing the prosthetic device may differentially affect patients with OSD, who may have preexisting LFU dysfunction, compared with DC patients, who presumably have a relatively normal LFU at baseline.
To evaluate these hypotheses, we conducted a prospective study that measured components of the LFU (basal tear production, corneal sensation, corneal subbasal nerve density and tortuosity, and corneal stromal nerve thickness) in a cohort of PROSE patients with either OSD or DC before device fitting had commenced and after 2 months of wearing the device had been achieved.
MATERIALS AND METHODS

Patients
This single-center, prospective, case-controlled study was conducted in the Department of Ophthalmology at the Weill Cornell Medical College. The study protocol was approved by the Weill Cornell Medical College Institutional Review Board, and the study performed in compliance with the Health Insurance Portability and Accountability Act regulations. Written informed consent was obtained from all patients.
Patients were recruited from the PROSE treatment program at the Weill Cornell Department of Ophthalmology between July 1, 2012, and April 1, 2013. Only patients who achieved long-term wear, defined as wearing the prosthetic device for at least 8 hour a day for a period of at least 60 days, were included. The 60-day time point was chosen because this represented a typical time for stabilization of wear and for likely stabilization of ocular surface parameters. Patients who had been fit previously with any scleral lenses were excluded. A single trained provider of PROSE prosthetic devices conducted the fitting process by assessing and customizing the device fit. Patients were evaluated approximately every 2 to 4 weeks over a 6-month period until optimal fit and comfort were achieved. At each visit, daily wear time was surveyed. Baseline measurements for tear production, corneal nerve sensation, and corneal nerve imaging (described below) were obtained before device fitting and wear. Repeat measurements were obtained after the patients reached longterm wear. Some patients deferred 1 or more measurements and were included in the analysis only for the tests with completed measurements. All measurements were obtained after removal of the prosthetic device.
Categorization of Diagnoses
Patients were categorized into 2 groups based on indication for PROSE treatment: (1) DC, including ectatic corneal diseases such as keratoconus, postrefractive surgery irregularity, pellucid marginal degeneration, and Terrien marginal degeneration; and (2) OSD, including primary DES, Sjögren syndrome, ocular graft-versus-host-disease, postrefractive surgery DES, DES associated with blepharitis, and exposure keratopathy. Patients with irregular astigmatism secondary to a diseased ocular surface were placed in the OSD category.
Tear Production
Schirmer type I with anesthesia was conducted to measure tear production. Patients were administered 1 drop of anesthetic, 0.5% proparacaine hydrochloride solution (Akorn, Inc, Lake Forest, IL), in each eye. A Schirmer strip was placed under the lower lid for 5 minutes with the patients' eyes closed. Tear production was measured in millimeters of wetted strip.
Central Corneal Sensation
Central corneal sensation was measured using a Cochet-Bonnet esthesiometer following the manufacturer's instructions. The tip of the nylon monofilament, starting at full length of 60 mm, was touched to the patient's central cornea until enough force was exerted that the filament bent. The filament was shortened by 5-mm increments until the patient felt contact of at least 3 of 5 touches, and that length was recorded. The maximum filament length is 60 mm, which exerts 11 mm/g of pressure on the cornea.
Confocal Microscopy
Corneal images were obtained using a ConfoScan 4 (Nidek, Inc, Freemont, CA) confocal scanning microscope, equipped with a ·40 immersion objective on which GenTeal Gel (Novartis Ophthalmics, Basel, Switzerland) was applied. Patients were administered 1 drop of 0.5% proparacaine hydrochloride solution in each eye. The lens was advanced until the gel contacted the cornea and the image was focused on the central cornea. Starting from the endothelial layer, 350 images of a 440-· 330-mm area were taken, with 5-mm steps between images. Each examination typically included 3 scans proceeding from the posterior to anterior cornea. A single best image showing nerves in the subbasal nerve plexus and stromal nerves was chosen from each examination. If no images of corneal nerves were obtained in the examination, the examination was excluded. Images were analyzed for subbasal corneal nerve fiber length and tortuosity, and stromal nerve trunk thickness using NeuroLucida Software (MBF Bioscience, Williston, VT). Subbasal epithelial nerve density was calculated by dividing the total length of nerve fibers in each image by the area photographed. Tortuosity is defined as the ratio of the length of the nerve segment divided by the distance between the endpoints. Triplicate measurements of the stromal nerve thickness were taken.
Statistical Analysis
We used a 2-way analysis of variance with repeated measures to determine statistical significance for each measurement. We compared the data at baseline and after long-term device wear between patients with DC and OSD. Sidek multiple comparisons test was used for post hoc tests to compare means between groups. A significance level of P , 0.05 was used for all tests. All statistical tests were conducted using GraphPad Prism version 6.00 (GraphPad Software, La Jolla, CA).
RESULTS
Baseline Characteristics
Twenty patients met the inclusion criteria of the study. Reported wear times ranged from 8 to 13 hours per day for a period of 61 to 190 days. The patient demographics and indication for PROSE treatment are presented in Table 1 . The number of patients included for each analysis is as follows: tear production, 18 patients (34 eyes); corneal sensitivity, 14 patients (20 eyes); subbasal density, 12 patients (21 eyes); subbasal tortuosity, 12 patients (21 eyes); and stromal thickness, 11 patients (17 eyes). Two eyes were excluded from the analysis of tear production because of an initial Schirmer test measurement of zero, indicating no measureable tear production. Fifteen eyes were excluded from the analysis of corneal sensation because of a baseline sensation at the maximal filament length of 60 mm.
Tear Production
Basal tear production in patients with DC significantly decreased after long-term wear of the PROSE prosthetic device (21.2 6 8.5 to 10.4 6 4.6 mm; P , 0.0001). In contrast, tear production did not change in patients with OSD after long-term wear (7.5 6 5.2 to 8.7 6 7.2 mm; P = 0.71). The statistical interaction of main effects between disease group and tear production over time was significant (P , 0.0001; Fig. 1A ).
Corneal Sensation
Corneal sensation in patients with DC was significantly increased after long-term wear of the prosthetic device (45.6 6 9.2 to 55.0 6 5.6 mm; P , 0.05). However, corneal sensation in patients with OSD was similar at baseline (45.0 6 8.7 mm) and after long-term wear (49.1 6 14.8 mm; P = 0.37). The statistical interaction of main effects between disease group and sensitivity over time was not significant (P = 0.26; Fig. 1B ).
Corneal Nerve Morphology
Representative confocal images of subbasal density, subbasal tortuosity, and stromal nerve thickness are shown in Figure 2 . Our testing did not demonstrate a significant change in subbasal nerve density in either OSD or DC patient groups. Subbasal nerve density in patients with corneal irregularity was 4719 6 1793 mm/mm 2 at baseline and 3066 6 1473 mm/mm 2 after long-term wear (P = 0.47). Subbasal density in patients with OSD was 7002 6 3137 mm/ mm 2 at baseline and 6166 6 3998 mm/mm 2 after long-term wear (P = 0.72). However, the between-subjects analysis showed that patients with DC have lower overall subbasal nerve density compared with patients with OSD (P , 0.05). The statistical interaction of main effects between the diagnosis group and subbasal nerve density over time was not significant (P = 0.66; Fig. 3A) .
Additional analysis of nerve morphology did not reveal any differences in critical nerve morphologic indices as a result of long-term wear of the PROSE prosthetic device. Subbasal nerve tortuosity in DC patients was 1.19 6 0.35 at baseline and 1.07 6 0.05 after long-term wear (P = 0.41). Patients with OSD had subbasal nerve tortuosity of 1.06 6 0.09 at baseline and 1.13 6 0.21 after long-term wear (P = 0.65). The statistical interaction of main effects between diagnosis group and tortuosity over time was not significant (P = 0.15; Fig. 3B ). Patients with DC had a stromal nerve thickness of 6.69 6 5.32 mm at baseline and 4.69 6 2.11 mm after long-term wear (P = 0.35). Stromal nerve thickness in patients with OSD was 5.74 6 2.10 mm at baseline and 5.33 6 1.95 mm after long-term wear (P = 0.89). There was no statistical interaction of main effects between diagnosis and stromal nerve thickness over time (P = 0.38; Fig. 3C ).
DISCUSSION
Our study is the first to show that long-term wear of an ocular surface prosthetic device can change corneal nerve function. During wear of the PROSE prosthetic device, the corneal surface is submerged in an aqueous reservoir, which prevents the corneal nerves from sensing the true ocular surface environment. Instead, the corneal nerves sense a wet saline environment devoid of the normal neuroendocrine and mechanical factors that provide feedback to regulate tear production. Furthermore, scleral lens application prevents evaporative tear loss, which abrogates evaporation-mediated cooling. This cooling is required to trigger cold receptors that set the basal tearing rate. 16, 17 Thus, the scleral lens interrupts chemical, mechanical, and thermal feedback mechanisms, resulting in a likely decreased stimulus for basal tear secretion.
Importantly, the LFU changes were observed in patients with DC but not in patients with OSD. The difference in disease pathophysiology between DC and OSD may provide insight into why these groups responded differently to longterm device wear. In patients with OSD, chronic dryness leads to lacrimal gland and ocular surface inflammation. Chronic inflammation causes release of cytokines and other inflammatory mediators that further damage the ocular surface, including the corneal nerves. 6, 8, 18 Thus, in OSD, the LFU components may be impaired, leading to a blunted response to long-term PROSE wear. However, patients with DC have primarily noninflammatory corneal disease with normal feedback mechanisms, and thus may respond to long-term device wear by decreasing baseline tear production. We also found that long-term device wear caused increased corneal sensation in patients with DC but not in those with OSD. Improvement of corneal sensation has important implications for patients with DC, and in particular, patients with keratoconus. Decreased corneal sensation is a hallmark of keratoconus, and corneal nerve function may be involved in the pathogenesis of the disease. [19] [20] [21] [22] Several studies have correlated decreased sensation to disease severity in patients with keratoconus. 23 Contact lenses, which are commonly worn by patients with keratoconus, further decrease sensation. 20 PROSE treatment seems to improve sensation and may provide added benefit for patients with keratoconus and other corneal irregularities. Currently, PROSE treatment is generally considered after failure to tolerate standard corneal contact lenses due to the added difficulty of prosthetic device insertion and added cost. Our study suggests that earlier implementation of PROSE treatment might be considered as it may have less undesired effects on corneal innervation compared with corneal contact lenses.
Unlike patients with DC, patients with OSD showed no significant change in corneal sensation in response to longterm wear of the device used in PROSE treatment. Changes in corneal sensation are more variable in patients with OSD compared with patients with corneal irregularities. Studies have reported both hyperesthesia and hypoesthesia in patients with dry eye and OSD, varying by etiology. For example, primary dry eye disease is associated with decreased corneal sensation, [24] [25] [26] whereas Sjögren syndrome is associated with increased sensation. 27, 28 The poorly understood effects of inflammation that accompanies OSD on corneal nerve function may explain the divergent responses of corneal sensation to OSD. We did not study each etiology of OSD separately, and thus cannot comment on specific effects of the prosthetic devices in the various causes of OSD.
Our examination of corneal nerve morphology did not find any changes after long-term device wear in either disease group. The clinical significance of subbasal nerve density is that decreased subbasal nerve density has been correlated to corneal sensation in a study of patients with keratoconus, 20 and studies on postrefractive surgery patients also concluded strong positive correlations between subbasal nerve density and corneal sensation. 29 In contrast, our results found that patients with corneal irregularity had improved corneal sensation after long-term wear but did not show any change in subbasal nerve density. However, we did find that patients with DC overall had a significantly lower subbasal nerve density compared with patients with OSD (between-subjects effect). It has previously been reported that patients with keratoconus have a lower subbasal nerve density than patients with normal corneas. 19, 22 In contrast, reports on subbasal nerve density in OSD have been varied. 24, 25 We did not find any significant change in subbasal tortuosity or stromal nerve thickness with long-term device wear in either patients with DC or OSD. Subbasal corneal nerve tortuosity has been previously shown to increase in some disease states, such as Sjögren syndrome, 28 and corneal stromal nerve thickness has previously been reported to be decreased in keratoconus 30, 31 and Sjögren syndrome. 28 One limitation to this analysis is that there is no standardized method for calculating tortuosity. Previously published methods include a scheme of grading tortuosity on a scale of 1 to 4, various approaches to calculate tortuosity from hand-traced nerve drawings, and grading with automated tracing of nerves. [32] [33] [34] The variation in methods makes comparisons between studies problematic. In addition, there is debate on the accuracy of quantitative analysis of stromal nerve thickness, because of the complexities of confocal imaging, making it difficult to obtain a reliable measurement. 29 This is the first study to evaluate the function and structure of the corneal nerves over the course of PROSE treatment; however, this study was limited by the relatively short follow-up time of 61 to 190 days. It is possible that the patients with OSD may require longer wear times to reverse the inflammatory nature of the disease, and a longer study period is needed to detect any changes in LFU function in this disease group. Future studies that follow patients for longer periods of time may allow for more accurate assessment, particularly regarding changes in corneal nerve morphology. Corneal nerve structure and morphology assessed by subbasal nerve density (A), tortuosity (B), and stromal nerve thickness (C). Measurements at baseline and after long-term device wear were compared and categorized by patient diagnosis. There was no change in subbasal nerve density, subbasal tortuosity, or stromal nerve thickness over time for either diagnosis group, but DC patients showed a lower density of subbasal nerves compared with patients with OSD.
In summary, our study showed that long-term wear of the prosthetic device used in PROSE treatment has significant effects on corneal nerve function in patients with corneal distortions. Because patients with DC have a healthier ocular surface, the intact LFU responds to the constant saline exposure by reducing the basal tear production and increasing corneal sensation, which are possible signs of improvement in corneal disease. However, patients with OSD did not have similar alterations in LFU function possibly because of ongoing inflammatory processes disrupting the LFU. As scleral lenses become more widely used as long-term therapies, the changes these devices confer on corneal neurobiology should be considered.
